Cargando…
Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis
TBI (traumatic brain injury) is one of the most common causes of deaths and failure to return to society according to the latest statistics. Cerebrolysin is a drug approved for use in patients diagnosed with TBI. It is a mixture of neuropeptides derived from purified porcine brain proteins and multi...
Autores principales: | Jarosz, Konrad, Kojder, Klaudyna, Andrzejewska, Agata, Solek-Pastuszka, Joanna, Jurczak, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046100/ https://www.ncbi.nlm.nih.gov/pubmed/36979317 http://dx.doi.org/10.3390/brainsci13030507 |
Ejemplares similares
-
Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis
por: Kojder, Klaudyna, et al.
Publicado: (2023) -
Comparison of Two Apnea Test Methods, Oxygen Insufflation and Continuous Positive Airway Pressure During Diagnosis of Brain Death: Final Report
por: Solek-Pastuszka, Joanna, et al.
Publicado: (2018) -
Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials
por: Strilciuc, Stefan, et al.
Publicado: (2021) -
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease
por: Nowak, Anna, et al.
Publicado: (2021) -
Atypical Pupil Reactions in Brain Dead Patients
por: Sołek-Pastuszka, Joanna, et al.
Publicado: (2021)